Pith. sign in

REVIEW 1 major objections 21 references

SAFE-Diff: Scale-Aware Attention and Feature-Dispersive Diffusion with Uncertainty Estimation for Contrast-Enhanced Breast MRI Synthesis

T0 review · 1 major / 0 minor · reviewed 2026-06-29 · grok-4.3

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read SAFE-Diff synthesizes high-fidelity contrast-enhanced breast MRI by combining scale-aware attention with feature-dispersive diffusion and uncertainty estimation.

desk verdict The abstract describes a diffusion model for contrast-enhanced breast MRI synthesis but supplies zero results or validation, so the claims cannot be checked. read the letter →

arxiv 2605.25767 v2 pith:ZBVWXYAQ submitted 2026-05-25 cs.CV

Tianyu Zhang , Xinglong Liang , Jarek van Dijk , Luyi Han , Chunyao Lu , Antonio Portaluri , Xinghe Xie , Yaofei Duan
show 8 more authors
Nika Rasoolzadeh Xin Wang Yuan Gao Muzhen He Yue Sun Jonas Teuwen Tao Tan Ritse Mann
This is my paper · ORCID
classification cs.CV
keywords contrast-enhancedMRIbreastcancerscreeningdiffusionmodelsimagesynthesisscale-awareattentionuncertaintyestimationfeaturedispersion
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper presents SAFE-Diff as a diffusion model designed to create synthetic contrast-enhanced breast MRI images from non-contrast scans. It argues that scale-aware attention handles varying lesion sizes, feature dispersion manages spread-out patterns, and uncertainty estimates flag unreliable regions, overcoming the stated difficulties of complex textures and heterogeneous enhancement. A sympathetic reader would see value in this because it points toward screening that avoids repeated gadolinium injections and their associated risks. The work frames the result as a direct response to the practical constraints of current breast cancer imaging workflows.

What carries the argument

SAFE-Diff, the named architecture that fuses scale-aware attention for multi-resolution lesion focus, feature-dispersive diffusion for distributing enhancement signals, and uncertainty estimation for reliability mapping during image synthesis.

What would settle it

A reader study in which radiologists show no improvement in lesion detection or characterization accuracy when using the synthetic contrast-enhanced images versus non-contrast images alone.

Watch

Extended reading notes

Core claim

The SAFE-Diff model, through its scale-aware attention and feature-dispersive diffusion process augmented by uncertainty estimation, produces contrast-enhanced breast MRI images of sufficient fidelity to address the challenges of complex lesion textures and heterogeneous enhancement patterns for clinical screening use.

Load-bearing premise

That adding scale-aware attention, feature dispersion in the diffusion steps, and uncertainty estimation will together overcome the difficulties of lesion textures and varying enhancement enough to yield images that are clinically usable.

Editorial extensions

If this is right

  • Screening protocols could reduce or eliminate gadolinium injections while maintaining diagnostic information.
  • Heterogeneous enhancement cases become more reliably handled without additional real scans.
  • Uncertainty maps allow selective review or rejection of low-confidence synthetic regions.
  • Workflow time and cost for breast MRI decrease because post-acquisition contrast synthesis replaces a second acquisition.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The same dispersion and uncertainty components could be tested on other contrast-enhanced modalities such as CT angiography.
  • Uncertainty outputs might feed into triage systems that decide when a real contrast scan is still required.
  • The model could be fine-tuned on longitudinal patient data to track changes in enhancement patterns over time.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit.

Referee Report

1 major / 0 minor

Summary. The paper claims that synthesizing high fidelity contrast enhanced MRI is clinically valuable for safer and more efficient breast cancer screening, yet remains challenging due to complex lesion textures and heterogeneous enhancement patterns; it proposes the SAFE-Diff model incorporating scale-aware attention, feature-dispersive diffusion, and uncertainty estimation to address these issues.

Significance. If validated with strong empirical results, the work could have clinical significance by enabling contrast-free MRI synthesis for breast cancer screening. The combination of scale-aware attention with feature-dispersive diffusion and uncertainty estimation represents a targeted extension of diffusion models to medical imaging challenges.

major comments (1)
  1. [Abstract] Abstract: the abstract states the clinical motivation and names the method but supplies no results, validation metrics, or evidence that the approach works as described. This absence prevents assessment of whether scale-aware attention, feature-dispersive diffusion, and uncertainty estimation suffice to handle the stated challenges of lesion textures and enhancement patterns.

Simulated Author's Rebuttal

1 responses · 0 unresolved

We thank the referee for the feedback. We agree that the abstract would benefit from including key results to allow readers to assess the method's performance on the stated challenges.

read point-by-point responses

  1. Referee: [Abstract] Abstract: the abstract states the clinical motivation and names the method but supplies no results, validation metrics, or evidence that the approach works as described. This absence prevents assessment of whether scale-aware attention, feature-dispersive diffusion, and uncertainty estimation suffice to handle the stated challenges of lesion textures and enhancement patterns.

    Authors: We agree with the observation. The provided abstract focuses on motivation and method naming without quantitative evidence. In the revised manuscript we will expand the abstract to report primary validation metrics (e.g., PSNR, SSIM, and uncertainty calibration scores) demonstrating that the proposed components improve fidelity on heterogeneous enhancement patterns and complex lesion textures. revision: yes

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity detected

full rationale

The provided document consists solely of the abstract and an explicit placeholder stating that full manuscript text is unavailable in the query. No equations, derivations, model architectures, loss functions, or self-citations are present for inspection. The central claim about scale-aware attention and feature-dispersive diffusion cannot be walked for any reduction to inputs by construction. This is the normal honest finding when no derivation chain exists in the supplied material.

Assumptions & free parameters 0 free parameters · 0 assumptions · 0 invented entities

No free parameters, axioms, or invented entities can be identified from the abstract alone.

how reviews work

0 comments
Cite this review

Pith. "Pith review of SAFE-Diff: Scale-Aware Attention and Feature-Dispersive Diffusion with Uncertainty Estimation for Contrast-Enhanced Breast MRI Synthesis." pith.science (2026). https://pith.science/paper/ZBVWXYAQ

@misc{pith2026260525767,
  author       = {Pith},
  title        = {Pith review of: SAFE-Diff: Scale-Aware Attention and Feature-Dispersive Diffusion with Uncertainty Estimation for Contrast-Enhanced Breast MRI Synthesis},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/ZBVWXYAQ}},
  note         = {Machine review of arXiv:2605.25767}
}
read the original abstract

Synthesizing high fidelity contrast enhanced MRI is clinically valuable for safer and more efficient breast cancer screening, yet remains challenging due to complex lesion textures and heterogeneous enhancement patterns.

Figures

Figures reproduced from arXiv: 2605.25767 by the authors.

Figure 1
Figure 1. The flowchart of this study. 2.2 Direct x0-Prediction Diffusion Framework SAFE-Diff adopts a diffusion-based generative framework that directly predicts the clean image x0 rather than the noise residual. Given a diffusion timestep t, Gaussian noise is added to the target image: xt = x0 + ϵt, ϵt ∼ N (0, σ2 t ). (1) The network regresses x0 from noisy input xt and condition c: (µ, log σ 2 ) = fθ([xt, c], t), (2) where… view at source ↗
Figure 2
Figure 2. Examples for synthetic contrast-enhanced breast MRI. . Qualitative results are shown in [PITH_FULL_IMAGE:figures/full_fig_p007_2.png] view at source ↗
Figure 3
Figure 3. Examples for uncertainty maps [PITH_FULL_IMAGE:figures/full_fig_p008_3.png] view at source ↗

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

21 extracted references · 1 canonical work pages

  1. [1]

    European radiology 30(3), 1436–1450 (2020) 10 T

    Baltzer, P., Mann, R.M., Iima, M., Sigmund, E.E., Clauser, P., Gilbert, F.J., Mar- tincich, L., Partridge, S.C., Patterson, A., Pinker, K., et al.: Diffusion-weighted imaging of the breast—a consensus and mission statement from the eusobi in- ternational breast diffusion-weighted imaging working group. European radiology 30(3), 1436–1450 (2020) 10 T. Zhang et al

    2020

  2. [2]

    CA: a cancer journal for clinicians 74(3), 229–263 (2024)

    Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., Je- mal, A.: Global cancer statistics 2022: Globocan estimates of incidence and mor- tality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 74(3), 229–263 (2024)

    2022

  3. [3]

    Radiology306(3), e213199 (2022)

    Chung,M.,Calabrese,E.,Mongan,J.,Ray,K.M.,Hayward,J.H.,Kelil,T.,Sieberg, R., Hylton, N., Joe, B.N., Lee, A.Y.: Deep learning to simulate contrast-enhanced breast mri of invasive breast cancer. Radiology306(3), e213199 (2022)

    2022

  4. [4]

    npj Artificial Intelligence1(1), 11 (2025)

    Dayarathna, S., Wu, Y., Cai, J., Wong, T.T., Law, M., Islam, K.T., Peiris, H., Chen, Z.: Mu-diff: a mutual learning diffusion model for synthetic mri with appli- cation for brain lesions. npj Artificial Intelligence1(1), 11 (2025)

    2025

  5. [5]

    Medical Image Analysis92, 103044 (2024)

    Han, L., Tan, T., Zhang, T., Huang, Y., Wang, X., Gao, Y., Teuwen, J., Mann, R.: Synthesis-based imaging-differentiation representation learning for multi-sequence 3d/4d mri. Medical Image Analysis92, 103044 (2024)

    2024

  6. [6]

    In: International Conference on Medical Image Computing and Computer-Assisted Intervention

    Han, L., Zhang, T., Huang, Y., Dou, H., Wang, X., Gao, Y., Lu, C., Tan, T., Mann, R.: An explainable deep framework: towards task-specific fusion for multi- to-one mri synthesis. In: International Conference on Medical Image Computing and Computer-Assisted Intervention. pp. 45–55. Springer (2023)

    2023

  7. [7]

    Insights into imaging12(1), 187 (2021)

    van der Hoogt, K.J., Schipper, R.J., Winter-Warnars, G.A., Ter Beek, L.C., Loo, C.E., Mann, R.M., Beets-Tan, R.G.: Factors affecting the value of diffusion- weighted imaging for identifying breast cancer patients with pathological com- plete response on neoadjuvant systemic therapy: a systematic review. Insights into imaging12(1), 187 (2021)

    2021

  8. [8]

    In: International Conference on Medi- cal Image Computing and Computer-Assisted Intervention

    Jiang, L., Mao, Y., Wang, X., Chen, X., Li, C.: Cola-diff: Conditional latent dif- fusion model for multi-modal mri synthesis. In: International Conference on Medi- cal Image Computing and Computer-Assisted Intervention. pp. 398–408. Springer (2023)

    2023

Show all 21 references
  1. [9]

    In: European conference on computer vision

    Johnson, J., Alahi, A., Fei-Fei, L.: Perceptual losses for real-time style transfer and super-resolution. In: European conference on computer vision. pp. 694–711. Springer (2016)

    2016

  2. [10]

    Medical physics 52(10), e70018 (2025)

    Lu, C., Tan, T., Yu, L., MohammadiNasab, P., Zhang, T., Zhang, H., Soryani, M., Mann, R., Kozegar, E., Bao, L.: Ai in breast imaging: A systematic review of reader studies evaluating design, performance, and clinical impact. Medical physics 52(10), e70018 (2025)

    2025

  3. [11]

    Radiology292(3), 520–536 (2019)

    Mann, R.M., Cho, N., Moy, L.: Breast mri: state of the art. Radiology292(3), 520–536 (2019)

    2019

  4. [12]

    Journal of the American Society of Nephrology17(9), 2359–2362 (2006)

    Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M.B., Heaf, J.G., Thomsen, H.S.: Nephrogenic systemic fibrosis: suspected causative role of gado- diamide used for contrast-enhanced magnetic resonance imaging. Journal of the American Society of Nephrology17(9), 2359–2...

    2006

  5. [13]

    Radiology307(3), e222211 (2023)

    Müller-Franzes, G., Huck, L., Tayebi Arasteh, S., Khader, F., Han, T., Schulz, V., Dethlefsen, E., Kather, J.N., Nebelung, S., Nolte, T., et al.: Using machine learning to reduce the need for contrast agents in breast mri through synthetic images. Radiology307(3), e222211 (2023)

    2023

  6. [14]

    DOI: https://doi

    Newitt, D., Partridge, S., Zhang, Z., Gibbs, J., Chenevert, T., Rosen, M., Bolan, P., Marques, H., Romanoff, J., Cimino, L., et al.: Acrin 6698/i-spy2 breast dwi [data set](2021). DOI: https://doi. org/10.7937/tcia. kk02-6d95 (2025)

    2021 doi

  7. [15]

    Radiology296(1), 122–130 (2020) SAFE-Diff 11

    Nguyen, N.C., Molnar, T.T., Cummin, L.G., Kanal, E.: Dentate nucleus signal intensity increases following repeated gadobenate dimeglumine administrations: a retrospective analysis. Radiology296(1), 122–130 (2020) SAFE-Diff 11

    2020

  8. [16]

    PloS one12(2), e0171704 (2017)

    Olchowy, C., Cebulski, K., Łasecki, M., Chaber, R., Olchowy, A., Kałwak, K., Zaleska-Dorobisz, U.: The presence of the gadolinium-based contrast agent deposi- tions in the brain and symptoms of gadolinium neurotoxicity-a systematic review. PloS one12(2), e0171704 (2017)

    2017

  9. [17]

    Physics in Medicine & Biology 68(10), 105004 (2023)

    Pan, S., Wang, T., Qiu, R.L., Axente, M., Chang, C.W., Peng, J., Patel, A.B., Shel- ton, J., Patel, S.A., Roper, J., et al.: 2d medical image synthesis using transformer- based denoising diffusion probabilistic model. Physics in Medicine & Biology 68(10), 105004 (2023)

    2023

  10. [18]

    In: Proceedings of the IEEE conference on computer vision and pattern recognition

    Zhang, R., Isola, P., Efros, A.A., Shechtman, E., Wang, O.: The unreasonable effectiveness of deep features as a perceptual metric. In: Proceedings of the IEEE conference on computer vision and pattern recognition. pp. 586–595 (2018)

    2018

  11. [19]

    In: International Conference on Medical Image Computing and Computer-Assisted Intervention

    Zhang, T., Han, L., D’Angelo, A., Wang, X., Gao, Y., Lu, C., Teuwen, J., Beets- Tan, R., Tan, T., Mann, R.: Synthesis of contrast-enhanced breast mri using t1-and multi-b-value dwi-based hierarchical fusion network with attention mechanism. In: International Conference on Medi...

    2023

  12. [20]

    Information Fusion108, 102381 (2024)

    Zhang, T., Tan, T., Han, L., Wang, X., Gao, Y., van Dijk, J., Portaluri, A., Gonzalez-Huete, A., D’Angelo, A., Lu, C., et al.: Important-net: integrated mri multi-parametric increment fusion generator with attention network for synthesiz- ing absent data. Information Fusion108...

    2024

  13. [21]

    Artificial Intelligence Review56(Suppl 1), 857–892 (2023)

    Zhang,T.,Tan,T.,Samperna,R.,Li,Z.,Gao,Y.,Wang,X.,Han,L.,Yu,Q.,Beets- Tan, R.G., Mann, R.M.: Radiomics and artificial intelligence in breast imaging: a survey. Artificial Intelligence Review56(Suppl 1), 857–892 (2023)

    2023

Pith tools

Reviewed June 29, 2026 · model on record in the stance chip above.